picryl chloride has been researched along with cysteine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Murakami, T; Sugita, T; Takata, I; Ueno, M | 1 |
Becker, D; Brand, P; Knop, J; Valk, E; Zahn, S | 1 |
Becker, D; Bruchhausen, S; Knop, J; Valk, E; Zahn, S | 1 |
Bukala, D; Fehrenbacher, B; Fuchs, K; Ghoreschi, K; Griessinger, CM; Gütschow, M; Haupt, D; Holstein, J; Kalbacher, H; Kneilling, M; Knopf, P; Laufer, S; Maurer, A; Mehling, R; Menendez, IG; Mucha, N; Pichler, BJ; Quintanilla-Martinez, L; Reinheckel, T; Röcken, M; Schaller, M; Schwenck, J | 1 |
4 other study(ies) available for picryl chloride and cysteine
Article | Year |
---|---|
The novel anti-rheumatic drug TA-383 has a macrophage migration enhancing activity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Reactive; Cell Movement; Chemotactic Factors; Collagen; Cysteine; Hypersensitivity, Delayed; Imidazoles; In Vitro Techniques; Macrophages, Alveolar; Mice; Mice, Inbred DBA; ortho-Aminobenzoates; Picryl Chloride; Rabbits; Sulfasalazine | 1997 |
Coupling of contact sensitizers to thiol groups is a key event for the activation of monocytes and monocyte-derived dendritic cells.
Topics: Acetates; Anti-Infective Agents; Antioxidants; Cysteine; Dendritic Cells; Ethylmaleimide; Humans; Interleukin-1; Lysine; Maleimides; MAP Kinase Signaling System; Monocytes; Phosphorylation; Picryl Chloride; Succinimides; Sulfhydryl Compounds; Sulfhydryl Reagents; Thiazoles; Tyrosine | 2003 |
Thiol antioxidants block the activation of antigen-presenting cells by contact sensitizers.
Topics: Acetylcysteine; Antigen-Presenting Cells; Antioxidants; Cells, Cultured; Cysteine; Dermatitis, Contact; Glutathione; Humans; Mitogen-Activated Protein Kinases; NF-kappa B; Phosphorylation; Picryl Chloride; Sulfhydryl Compounds; Tyrosine | 2003 |
Cysteine-type cathepsins promote the effector phase of acute cutaneous delayed-type hypersensitivity reactions.
Topics: Acute Disease; Animals; Catalytic Domain; Cathepsins; Chronic Disease; Cysteine; Female; Humans; Hypersensitivity, Delayed; Inflammation; Mice, Inbred C57BL; Optical Imaging; Picryl Chloride; Protease Inhibitors; Skin | 2019 |